Tratamiento de verrugas vulgares múltiples y recalcitrantes con 1-cloro-2, 4 dinitrobenceno (DNCB) o placebo en pacientes pediátricos

Rosado Cancino, M. A; Ruiz Maldonado, Ramón; Tamayo, Lourdes; Laterza, Amelia M.
Dermatol. rev. mex ; 33(4): 245-52, jul.-ago. 1989. tab
Artículo en Español | LILACS | ID: lil-111027

Documentos relacionados

  1. [Treatment of verruca with DNCB].
  2. [Treatment of common warts with topically applied DNCB (author's transl)].
  3. Exosomes derived from human dermal fibroblasts (HDFn-Ex) alleviate DNCB-induced atopic dermatitis (AD) via PPARα.
  4. Topical treatments for cutaneous warts.
  5. Local treatments for cutaneous warts.
  6. Local treatments for cutaneous warts.
  7. [The treatment of common warts with 2,4-dinitrochlorobenzene (DNCB)].
  8. Vasicine alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis and passive cutaneous anaphylaxis in BALB/c mice.
  9. PYR-41, an inhibitor of ubiquitin-activating enzyme E1, attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice.
  10. Protective Effects of Topical Administration of Laminarin in Oxazolone-Induced Atopic Dermatitis-like Skin Lesions.